[PDF][PDF] ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state.

N Glaser, M Fritsch, L Priyambada, A Rewers… - Pediatric …, 2022 - endoped.ro
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetic ketoacidosis and hyperglycemic
hyperosmolar state Page 1 ISPAD GUIDELINES ISPAD Clinical Practice Consensus …

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

AK Singh, R Gupta, A Ghosh, A Misra - Diabetes & Metabolic Syndrome …, 2020 - Elsevier
Background and aims High prevalence of diabetes makes it an important comorbidity in
patients with COVID-19. We sought to review and analyze the data regarding the …

Management of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus

L Castellanos, M Tuffaha, D Koren, LL Levitsky - Pediatric Drugs, 2020 - Springer
Diabetic ketoacidosis (DKA) is the end result of insulin deficiency in type 1 diabetes mellitus
(T1D). Loss of insulin production leads to profound catabolism with increased …

[HTML][HTML] Adult diabetic ketoacidosis

JM Lizzo, A Goyal, V Gupta - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Objectives: Review the etiology of diabetic ketoacidosis. Describe the management of a
patient with diabetic ketoacidosis. Summarize the abnormal laboratory parameters in a …

COVID-19: diabetes perspective—pathophysiology and management

S Dallavalasa, SRV Tulimilli, J Prakash… - Pathogens, 2023 - mdpi.com
Recent evidence relating to the impact of COVID-19 on people with diabetes is limited but
continues to emerge. COVID-19 pneumonia is a newly identified illness spreading rapidly …

ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID‐19 and resource‐limited settings‐role of subcutaneous insulin

L Priyambada, JI Wolfsdorf, SJ Brink… - Pediatric …, 2020 - Wiley Online Library
Abstract The International Society for Pediatric and Adolescent Diabetes Clinical Practice
Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the …

COVID-19 and diabetes: will novel drugs for diabetes help in COVID-19?

HM Al-Kuraishy, AI Al-Gareeb… - Current Molecular …, 2023 - ingentaconnect.com
COVID-19 is caused by the SARS-CoV-2 virus, which has afflicted more than 245.37 million
individuals worldwide and resulted in more than 4.9 million deaths as of today, with a …

[HTML][HTML] Efficacy and safety of intravenous insulin in treatment of patient with diabetic ketoacidosis: a systematic review and meta-analysis

KS Alshurtan, O Alnizari, H Aldarwish, AA Al-Tufaif - Cureus, 2022 - ncbi.nlm.nih.gov
The most common acute hyperglycemic emergency is diabetic ketoacidosis (DKA). DKA is
one of the leading causes of Type 1 diabetes (T1D) related deaths in people aged 30 and …

[HTML][HTML] COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments

I Gilyazova, Y Timasheva, A Karunas… - Non-coding RNA …, 2023 - Elsevier
The novel coronavirus infection (COVID-19) causes a severe acute illness with the
development of respiratory distress syndrome in some cases. COVID-19 is a global problem …

Analysis of curative effect of insulin external application on burn wounds of diabetic patients with different depths

M Yang, C Li, X Xue, W Wei, L Xing… - International Wound …, 2023 - Wiley Online Library
To explore the curative effect of insulin external application on burn wounds of diabetic
patients with different depths. A retrospective analysis of 114 diabetic burn patients in the …